GeneDx Holdings Corp.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $19.0M | $-330.1M | $108.1M |
| FY2021 | $18.5M | $-521.8M | $58.7M |
| FY2022 | $6.3M | $253.7M | $123.9M |
| FY2023 | $52.7M | $228.0M | $99.7M |
| FY2024 | $51.9M | $245.2M | $85.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $19.0M | $-330.1M | $108.1M |
| FY2021 | $18.5M | $-521.8M | $58.7M |
| FY2022 | $6.3M | $253.7M | $123.9M |
| FY2023 | $52.7M | $228.0M | $99.7M |
| FY2024 | $51.9M | $245.2M | $85.2M |